Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of commercial antibodies against human sphingosine-1-phosphate receptor 1.
Co-occurring Depression and Pain in Multiple Sclerosis.
Interleukin-1β and Interleukin-1 Receptor Antagonist Appear in Grey Matter Additionally to White Matter Lesions during Experimental Multiple Sclerosis.
Inverse and Direct Cancer Comorbidity in People with Central Nervous System Disorders: A Meta-Analysis of Cancer Incidence in 577,013 Participants of 50 Observational Studies.
Functional neuroimaging may quantify spinal cord demyelinating disease.
Rad51 Activates Polyomavirus JC Early Transcription.
Genome-wide association studies in neurology.
The therapeutic potential of cannabinoids for movement disorders.
Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
Dimethyl fumarate in the management of multiple sclerosis: appropriate patient selection and special considerations.
[Differntial diagnosis of neuromyelitis optica].
The brain as 'immunoprecipitator' of serum autoantibodies against NMDAR1.
Neuron-macrophage crosstalk in the intestine: a "microglia" perspective.
Motor unit number index (MUNIX): Is it relevant in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortem.
Appendix: clinical evaluation and treatment of transverse myelitis.
Memory impairment in multiple sclerosis: Relevance of hippocampal activation and hippocampal connectivity.
Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.
Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE).
The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
Imaging gray matter with concomitant null point imaging from the phase sensitive inversion recovery sequence.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Robotic gait rehabilitation and substitution devices in neurological disorders: where are we now?
Pages
« first
‹ previous
…
622
623
624
625
626
627
628
629
630
…
next ›
last »